Coronavirus Disease 2019: Virology and Drug Targets

Praveen Thaggikuppe Krishnamurthy1

  • 1Department of Pharmacology, JSS College of Pharmacy, (A constituent College of JSS Academy of Higher Education & Research), Ooty, Tamilnadu,India.

Insights

This review explores Coronavirus Disease 2019 (COVID-19) virology and drug repurposing strategies. It details SARS-CoV-2 proteins and current antiviral drug development, focusing on FDA-approved medications.

Area of Science:

  • Virology
  • Drug Discovery
  • Infectious Diseases

Background:

  • The Coronavirus Disease 2019 (COVID-19) pandemic, caused by SARS-CoV-2, poses significant global health and economic challenges.
  • Vaccine development is ongoing, but immediate therapeutic strategies are crucial.

Purpose of the Study:

  • To review the current understanding of SARS-CoV-2 virology, including its structural, non-structural, and accessory proteins.
  • To discuss various drug discovery strategies, with a focus on repurposing FDA-approved drugs.
  • To summarize the current status of antiviral drug development for COVID-19.

Main Methods:

  • Literature review of SARS-CoV-2 virology.
  • Analysis of drug repurposing, artificial intelligence, and high-throughput screening methodologies.
  • Examination of current antiviral drug development pipelines.

Main Results:

  • Detailed overview of key SARS-CoV-2 target proteins: S-glycoprotein, 3-chymotrypsin-like protease, papain-like protease, RNA-dependent RNA polymerase, and helicase.
  • Exploration of drug repurposing as a viable strategy for rapid therapeutic development.
  • Summary of promising antiviral candidates and their developmental stages.

Conclusions:

  • Drug repurposing offers a promising avenue for accelerating the availability of COVID-19 treatments.
  • Continued research into SARS-CoV-2 targets and drug discovery methods is essential.
  • Understanding viral mechanisms is key to developing effective antiviral therapies.

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.1K
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
24.3K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
445
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.5K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.4K
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
320